Teva Pharmaceutical Industries Ltd TEVA Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	44.01B	43.46B	43.1B	42.09B	43.48B	42.77B	41.34B	41.76B
Total Current Assets	12.05B	11.5B	12.09B	11.43B	12.49B	12.3B	11.63B	12.31B
Cash and Equivalents	2.8B	2.14B	2.67B	2.25B	3.23B	2.99B	2.26B	3.32B
Total Non-Current Assets	37.69B	31.96B	31.01B	30.66B	36.74B	30.48B	29.71B	29.44B
Total Liabilities	35.32B	34.84B	35.39B	34.58B	35.35B	35.23B	34.78B	35.38B
Total Current Liabilities	11.47B	10.41B	11.84B	11.39B	12.25B	13.79B	13.04B	13.8B
Total Non-Current Liabilities	42.95B	44.1B	42.24B	41.68B	41.27B	38.02B	38.29B	37.98B
Common Equity	57M	57M	57M	57M	57M	58M	58M	58M
Retained Earnings	-12.88B	-13.09B	-13.95B	-13.87B	-13.53B	-13.67B	-14.52B	-14.96B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	92.89B	70.62B	60.68B	57.47B	50.64B	47.67B	44.01B	43.48B
Total Current Assets	16.96B	15.38B	13.79B	13.46B	13.01B	12.57B	12.05B	12.49B
Cash and Equivalents	988M	963M	1.78B	1.98B	2.18B	2.17B	2.8B	3.23B
Total Non-Current Assets	34.99B	18.75B	15.79B	15.06B	11.06B	11.24B	8.69B	8.13B
Total Liabilities	57.9B	51.87B	44.89B	42.41B	39.58B	36.42B	35.32B	35.35B
Total Current Liabilities	18.52B	17.92B	14.32B	13.67B	13.17B	11.03B	11.47B	12.25B
Total Non-Current Liabilities	71.9B	62.78B	57.27B	53.3B	49.15B	47.01B	42.95B	41.27B
Total Equity	34.99B	18.75B	15.79B	15.06B	11.06B	11.24B	8.69B	8.13B
Common Equity	3.67B	3.69B	56M	56M	57M	57M	57M	57M
Retained Earnings	13.61B	-3.8B	-5.96B	-6.96B	-10.95B	-10.53B	-12.88B	-13.53B